Product Images Neuraceq

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Neuraceq NDC 54828-001 by Life Molecular Imaging, Ltd, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure - figure

figure - figure

The text describes different regions of the brain: Cerebellum, Lateral temporal, Frontal lobes, Posterior cingulate/Parietal lobes, and Precuneus. It also mentions "Neuraceq" and two possible scan results: "Negative Scan" and "Positive Scan". Neuraceq is likely a medical imaging agent used for positron emission tomography (PET) scans to visualize beta-amyloid plaques in the brain, which are associated with Alzheimer's disease.*

shield label nm 06 2022 fda approved LMI

shield label nm 06 2022 fda approved LMI

This text provides information about a medical product called Neuraceq®. It is a sterile non-pyrogenic injection used for diagnostic purposes, meant for intravenous use only. Each ml of the injection contains up to 3 meg of lrbetaben and 50 MBa/mL to 5,000 MBymL, along with other components such as ascorbic acid and sodium ascorbate. It is recommended to dispense the injection aseptically and store it at room temperature or within 2 to 42°C (36°F to 108°F). The text includes details on dosage and storage instructions, as well as batch number and expiration date.*

shield label sofie 06 2022 fda approved LMI

shield label sofie 06 2022 fda approved LMI

This is a description of Neuraceq, a sterile non-pyrogenic injectable radioactive drug used for intravenous diagnosis. It comes in a 50 mL multiple-dose vial and contains up to 3 meg of arbefaben and 50 MBa to 5,000 MBymL with other additives. The recommended dose is specified in the prescribing information. It should be dispensed into a sterile syringe or container within a lead shielded secondary container. It should be stored upright in its original container or its radiation shielding equivalent. The storage temperature should be maintained at 5°C with excursions permitted to 2°C to 42°C. It is not recommended to use the drug if it contains cloudy or particulate matter. The drug can only be used by RxONLY, and it has a batch number and expiration date/time.*

structure - structure

structure - structure

vial label nm 06 2022 fda approved LMI

vial label nm 06 2022 fda approved LMI

This is a description of a medication called Newacea SterleNon-rogenc Darheiaben. It is intended for intravenous use only and comes in a 50mL vial. Each vial contains 3g of Sotetlan and additional ingredients such as ascorbic acid and sodium ascorbate. The medication should be stored at temperatures between 2°C to 42°C. It is important to store it in a radiation shielding container and not use it if it appears cloudy or contains particulate matter.*

vial label sofie 06 2022 fda approved LMI

vial label sofie 06 2022 fda approved LMI

This is a description of a diagnostic injection for intravenous use only. It comes in a 50 mL multiple-dose vial with a shelf life of 10 months after the expiration date mentioned. The injection contains up to 3 grams of Sotetlia, 44 mg of Ascorbic Acid, and 118 mg of stanel among other ingredients. The injection must be stored upright between 2°C to 42°C and away from cloudy or particulate matter.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.